Israel · Delayed Price · Currency is ILS · Price in ILA SofWave Medical Statistics
Total Valuation
SofWave Medical has a market cap or net worth of ILS 1.56 billion. The enterprise value is 1.46 billion.
| Market Cap | 1.56B |
| Enterprise Value | 1.46B |
Important Dates
The last earnings date was Tuesday, March 17, 2026.
| Earnings Date | Mar 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SofWave Medical has 36.12 million shares outstanding. The number of shares has increased by 15.83% in one year.
| Current Share Class | 36.12M |
| Shares Outstanding | 36.12M |
| Shares Change (YoY) | +15.83% |
| Shares Change (QoQ) | +1.04% |
| Owned by Insiders (%) | 34.48% |
| Owned by Institutions (%) | 24.03% |
| Float | 17.14M |
Valuation Ratios
The trailing PE ratio is 97.02.
| PE Ratio | 97.02 |
| Forward PE | n/a |
| PS Ratio | 5.60 |
| PB Ratio | 15.00 |
| P/TBV Ratio | 15.00 |
| P/FCF Ratio | 38.45 |
| P/OCF Ratio | 36.90 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 52.67, with an EV/FCF ratio of 35.81.
| EV / Earnings | 83.29 |
| EV / Sales | 5.21 |
| EV / EBITDA | 52.67 |
| EV / EBIT | 66.54 |
| EV / FCF | 35.81 |
Financial Position
The company has a current ratio of 2.30, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.30 |
| Quick Ratio | 1.97 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.13 |
| Debt / FCF | 0.09 |
| Interest Coverage | 99.54 |
Financial Efficiency
Return on equity (ROE) is 19.17% and return on invested capital (ROIC) is 534.57%.
| Return on Equity (ROE) | 19.17% |
| Return on Assets (ROA) | 8.69% |
| Return on Invested Capital (ROIC) | 534.57% |
| Return on Capital Employed (ROCE) | 20.54% |
| Weighted Average Cost of Capital (WACC) | 7.90% |
| Revenue Per Employee | 1.85M |
| Profits Per Employee | 115,845 |
| Employee Count | 126 |
| Asset Turnover | 1.77 |
| Inventory Turnover | 3.99 |
Taxes
In the past 12 months, SofWave Medical has paid 793,812 in taxes.
| Income Tax | 793,812 |
| Effective Tax Rate | 4.34% |
Stock Price Statistics
The stock price has increased by +167.95% in the last 52 weeks. The beta is 0.66, so SofWave Medical's price volatility has been lower than the market average.
| Beta (5Y) | 0.66 |
| 52-Week Price Change | +167.95% |
| 50-Day Moving Average | 3,809.66 |
| 200-Day Moving Average | 3,096.69 |
| Relative Strength Index (RSI) | 62.35 |
| Average Volume (20 Days) | 88,545 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SofWave Medical had revenue of ILS 279.39 million and earned 17.49 million in profits. Earnings per share was 0.45.
| Revenue | 279.39M |
| Gross Profit | 210.28M |
| Operating Income | 21.90M |
| Pretax Income | 18.29M |
| Net Income | 17.49M |
| EBITDA | 25.21M |
| EBIT | 21.90M |
| Earnings Per Share (EPS) | 0.45 |
Balance Sheet
The company has 110.78 million in cash and 3.58 million in debt, with a net cash position of 107.20 million or 2.97 per share.
| Cash & Cash Equivalents | 110.78M |
| Total Debt | 3.58M |
| Net Cash | 107.20M |
| Net Cash Per Share | 2.97 |
| Equity (Book Value) | 104.28M |
| Book Value Per Share | 2.85 |
| Working Capital | 92.21M |
Cash Flow
In the last 12 months, operating cash flow was 42.38 million and capital expenditures -1.70 million, giving a free cash flow of 40.68 million.
| Operating Cash Flow | 42.38M |
| Capital Expenditures | -1.70M |
| Depreciation & Amortization | 3.08M |
| Net Borrowing | -2.40M |
| Free Cash Flow | 40.68M |
| FCF Per Share | 1.13 |
Margins
Gross margin is 75.27%, with operating and profit margins of 7.84% and 6.26%.
| Gross Margin | 75.27% |
| Operating Margin | 7.84% |
| Pretax Margin | 6.55% |
| Profit Margin | 6.26% |
| EBITDA Margin | 9.02% |
| EBIT Margin | 7.84% |
| FCF Margin | 14.56% |
Dividends & Yields
SofWave Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.83% |
| Shareholder Yield | -15.83% |
| Earnings Yield | 1.12% |
| FCF Yield | 2.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SofWave Medical has an Altman Z-Score of 7.35 and a Piotroski F-Score of 6.
| Altman Z-Score | 7.35 |
| Piotroski F-Score | 6 |